Bregman C.L., Willia P.D. (1986) Comparative nephrotoxicity of carboplatin and cisplatin in combination with tobramycin. Cancer Chemother Pharmacol 18:117-123.
Burton K. (1956) A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62:315-323.
Calvert A.H., Harland S.J., Newell R.D., Siddik Z.H., Jones A.C., McElwain T.J., Raju S., Wiltshaw E., Smith I.E., Baker J.M., Peckham M.J., Harrap K.R. (1982) Early clinical studies with cis-diammine-1, 1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol 9:140-147.
Calvert A.H., Harland S.J., Newell D.R., Siddik Z.H., Harrap K.W. (1985) Phase I studies with carboplatin at the Royal Marsden Hospital. Cancer Treat Rev 12:51-57.
.
Carlier M.B. (1984) La phospholipidose rénale induite par les aminoglycosides. Etude biochimique et morphologique, Thesis Université Catholique de Louvain, Belgium; .
Choie D.D., Langnecker D.S., del Campo A.A. (1981) Acute and chronic cis-platin nephropathy in rat. Lab Invest 44:397-402.
Chopra S., Kaufman J.S., Jones T.W., Hong W.K., Gehr M.K., Hamburger R.J., Flamenbaum W., Trump B.F. (1982) Cis-diamminedichloroplatinum-induced acute renal failure in the rat. Kidney Int 21:54-64.
Cuppage F.E., Tate A. (1967) Repair of the nephron following injury with mercuric chloride. Am J Pathol 51:405-429.
Cuppage F.E., Cunningham N., Tate A. (1969) Nucleic acid synthesis in the regenerating nephron following injury with mercuric chloride. Lab Invest 21:449-457.
Dobyan D.C., Levi J., Jacobs C., Kosek J., Weiner M.W. (1980) Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. J Pharmacol Exp Ther 213:551-556.
Dobyan D.C., Hill D., Lewis T., Bulger R.E. (1981) Cyst formation in rat kidney induced by cis-platinum administration. Lab Invest 45:260-268.
Dobyan D.C. (1985) Long-term consequences of cis-platinum-induced renal injury: a structural and functional study. Anat Rec 212:239-245.
Einhorn L.H., Crawford J., Birch R., Omura G., Johnson D.H., Greco F.A. (1988) Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited smallcell lung cancer. J Clin Oncol 6:451-456.
Engineer, Bodey G.P., Newman R.A., Ho D.W. (1987) Effects of cisplatin-induced nephrotoxicity on gentamicin pharmacokinetics in rats. J Pharmacol Exp Ther 15:329-334.
Gandara D.R., Perez E.A., Phillips W.A., Lawrence H.J., De Gregorio M. (1989) Evaluation of cisplatin dose intensity: current status and future prospects. Anticanc Res 9:1121-1128.
Ghadially F.N. Ultrastructural pathology of the cell and matrix , Butterworths, London; 1982, 558.
Giuliano R.A., Verpooten G.A., Verbist L., Wedeen R., De Broe M.E. (1986) In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats. J Pharmacol Exp Ther 236:470-475.
Haas A., Lad L.A.T. (1983) The influence of aminoglycosides on the nephrotoxicity of cis-diamminedichloroplatinum in cancer patients. J Infect Dis 147:363.
Holleran W.M., De Gregorio M.W. (1988) Evolution of high-dose cisplatin. Invest New Drugs 6:135-142.
Houghton D.C., Lee E., Gilbert D.N., Bennett W.M. (1986) Chronic gentamicin nephrotoxicity: continued tubular injury with preserved glomerular filtration function. Am J Pathol 123:183-194.
Jones T.W., Chopra S., Kaufman J.S., Flamenbaum W., Trump B.F. (1985) Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat. Lab Invest 52:363-374.
Kahlmeter G., Dahlger J.I. (1984) Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982. J Antimicrob Chemoth 13:9-32.
Kawamura J., Soeda A., Yoshida O. (1981) Nephrotoxicity of cisdiamminedichloroplatinum (II) (cis-Platinum) and the additive effect of antibiotics: morphological and functional observation in rats. Toxicol Appl Pharmacol 58:475-482.
Kosek J., Mazze R., Cousins M. (1974) Nephrotoxicity of gentamicin. Lab Invest 30:48-57.
Laurent G., Maldague P., Carlier M., Tulkens P. (1983) Increased renal DNA synthesis in vivo after administration of low doses of gentamicin to rats. Antimicrob Agents Chemother 24:586-593.
Laurent G., Toubeau G., Heuson-Stiennon J.A., Tulkens P.M., Maldague P. (1988) Kidney tissue repair after nephrotoxic injury: Biochemical and morphological characterization. CRC Crit Rev Toxicol 19:147-183.
Laurent G., Yernaux V., Nonclercq D., Toubeau G., Maldague P., Tulkens P.M., Heuson-Stiennon J.A. (1988) Tissue injury and proliferative response induced in rat kidney by cis-diammine dichloroplatinum II. Virchows Arch [B] 55:129-145.
Lietman P.S. (1985) Aminoglycosides and spectinomycin: Aminocyclitols. Principles and practice of infectious diseases , G.L., Mandell, R.G., Douglas, J.E., Bennett, Wiley, New York; 192-206.
Loehrer P.J., Einhorn L.H. (1984) Diagnosis and treatment. Drugs five years later: cisplatin. Ann Int Med 100:704-713.
Luft F.C., Kleit S.A. (1974) Renal parenchymal accumulation of aminoglycoside antibiotics in rats. J Infect Dis 130:656-659.
Mavichak V., Wong N.L.N., Quamme G.A., Sutton R.A.L., Dirks J.H. (1985) Studies on the pathogenesis of cisplatin-induced hypomagnesemia in the rat. Kidney Int 28:914-921.
Meijer D., Sleijfer D.T., Mulder N.H., Donker A.J.M. (1982) Cisplatininduced nephrotoxicity. Neth J Med 25:262-269.
Munro H.N., Fleck A. (1966) The determination of nucleic acids. Meth Biochem Anal 14:113-176.
Nichols C.R., Loehrer P.J., Greist A., Kubilis P.S., Hoffman R. (1988) Salvage chemotherapy for lymphoma with VP-16, ifofamide, and cisplatin. Med Pediatr Oncol 16:12-16.
Nonclercq D., Toubeau G., Laurent G., Maldague P., Tulkens P., Heuson-Stiennon J.A. (1988) Light and electron microscopic characterization of the proliferative response induced by tobramycin in rat kidney cortex. Exp Mol Pathol 48:335-352.
Nonclercq D., Toubeau G., Laurent G., Tulkens P.M., Heuson-Stiennon J.A. (1989) Nephrotoxic injury and renal tissue repair associated with the administration of the anticancer drugs cisplatin and carboplatin. Micron Microscop Acta 20:51-58.
Nonclercq D., Toubeau G., Laurent G., Tulkens P.M., Heuson-Stiennon J.A. (1989) Tissue injury and repair in the rat kidney after exposure to cisplatin and carboplatin. Exp Mol Pathol 51:123-140.
Peckham M.J., Horwich A., Hendry W.F. (1985) Advanced seminoma: Treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8). Br J Cancer 52:7-13.
Prestayko A.W. (1981) Cisplatin and analogues: a new class of anticancer drugs. Cancer and chemotherapy, vol III, antineoplatic agents , S.T., Crooke, A.W., Prestayko, Academic Press, New York; 133-154.
Safirstein R., Winston J., Guttenplan G. (1986) Cisplatin nephrotoxicity: physiological and biochemical aspects. Biochemical mechanisms of platinum antitumor drugs , McBrien, T.F., Slater, I.R.L. Press Lim, Oxford; 271-306.
Safirstein R., Winston J., Moel D., Dikman S., Guttenplan J. (1987) Cisplatin nephrotoxicity: insight into mechanism. Int J Androl 10:325-346.
Safirstein R., Zelent A.Z., Gordon R. (1988) Cisplatin Nephrotoxicity: new insights into mechanism. Organ directed toxicities of anticancer drugs , M.P., Hacker, J.S., Lazo, T.R., Tritton, Martinus Nijhoff, Boston; 172-189.
Sande M.A., Mandell G.L. (1985) Antimicrobial agents. The aminoglycosides. The pharmacological basis of therapeutics , A., Goodman Gilman, L.S., Goodman, T.W., Rall, F., Murad, MacMillan, New York; 1150-1169.
Schroyens W.A., Meeker J.B., Dodion P., Stryckmans P.A., Rozencweig M. (1988) Comparative effect of cisplatin, spiroplatin, carboplatin, iproplatin and JM40 in a human myeloid clonogenic assay. Eur J Cancer Clin Oncol 24:1309-1312.
Smith I.E., Harland S.J., Robinson B.A., Evans B.D., Goodhart L.C., Calvert A.H., Yarnold J., Glees J.P., Baker J., Ford H.T. (1985) Carboplatin: A very active new cisplatin analog in the treatment of small cell lung cancer. Cancer Treat Rep 69:43-46.
Tay L.K., Bregman C.L., Masters B.A., Willia P.D. (1988) Effects of cis-diamminedichloroplatinum (II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture. Cancer Res 48:2538-2543.
Ten Bokkel Huinink W.W., Van Der Burg M.E.L., Van Oosterom A.T., Neijt J.P., George M., Guastala J.P., Veenhof C.H.N., Rotmensz N., Dalesio O., Vermorken J.B. (1988) Carboplatin in combination therapy for ovarian cancer. Cancer Treatment Reviews 15:9-15.
Toubeau G., Laurent G., Carlier M.B., Abid S., Maldague P., Heuson-Stiennon J.A., Tulkens P. (1986) Tissue repair in rat kidney cortex after short treatment with aminoglycosides at low doses. A comparative biochemical and morphometric study. Lab Invest 54:385-393.
Toubeau G., Maldague P., Laurent G., Vaamonde C.A., Tulkens P.M., Heuson-Stiennon J.A. (1986) Morphological alterations in distal and collecting tubules of the rat renal cortex after aminoglycoside administration at low doses. Virchows Archiv B Cell Pathology Including Molecular Pathology 51:475-485.
Tulkens P.M. (1989) Nephrotoxicty of aminoglycoside antibiotics. Toxicol Lett 46:107-123.
Ward J.M., Fauvie K.A. (1976) The nephrotoxic effects of cis-diamminedi-chloroplatinum II (NSC-119875) in male F344 rats. Toxicol Appl Pharmacol 38:535-547.
Watanabe M. (1978) Drug-induced lysosomal changes and nephrotoxicity in rats. Acta Pathol Jpn 28:867-889.
Wiltshaw E., Evans B.D., Jones A.C., Baker J.W., Calvert A.H. (1983) JM8 successor to cisplatin in advanced ovarian carcinoma?. Lancet 1:587.
Wiltshaw E., Evans B., Harland S. (1985) Phase III randomized trial cisplatin versus JM8 (carboplatin) in 112 ovarian cancer patients, stages III and IV. Proc Am Assoc Clin Oncol 4:121.
